Han Jing-Yan, Horie Yoshinori, Li Dan, Akiba Yasutada, Nagata Hiroshi, Miura Soichiro, Oda Masaya, Ishii Hiromasa, Hibi Toshifumi
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Clin Hemorheol Microcirc. 2006;34(1-2):145-50.
Myakuryu (MR) is a newly developed herbal medicine composing Crataegue oinnatifida bge (COB), Panax notoginseng (PN) and Ginkyo biloba (GB). To examine the effectiveness of MR, we investigated its effects on rat mesenteric microcirculatory injury induced by ischemia/reperfusion (I/R). The mesenteric microcirculation of ileocecal portion of a male Wistar rat was observed through an inverted-type intravital microscope assisted with a charge-coupled devise (CCD) camera. Mesenteric I/R was conducted by a ligation of the mesenteric artery and vein (10 min) and subsequent release of the occlusion. We measured venular diameter, the number of adherent leukocytes, dihydrorhodamine 123 (DHR) fluorescence as an indicator of oxidative stress and mast cell degranulation, with or without MR extract (0.4 g/kg b.w.) via an orogastric tube 1 hr before I/R. The diameters of the observed mesenteric venules were not changed after the mesenteric I/R. MR had no effect on venular diameter. The leukocytes adhering to the post-capillary venular walls started just after reperfusion, and increased thereafter. The increased number of adherent leukocytes was significantly reduced by treatment with MR. DHR fluorescence ratio was significantly increased along the venular wall. MR attenuated the increased oxidation. The mesenteric I/R induced mast cell degranulation. The increase in mast cell degranulation was inhibited by MR. In conclusion, oral administration of MR attenuates I/R-induced microvascular damages in rat mesentery. MR has a therapeutic potential for prevention of I/R-related microvascular injury.
妙龙(MR)是一种新开发的草药,由山楂(COB)、三七(PN)和银杏(GB)组成。为了研究MR的有效性,我们研究了其对缺血/再灌注(I/R)诱导的大鼠肠系膜微循环损伤的影响。通过配备电荷耦合器件(CCD)相机的倒置式活体显微镜观察雄性Wistar大鼠回盲部的肠系膜微循环。肠系膜I/R通过结扎肠系膜动静脉(10分钟)并随后解除闭塞来进行。在I/R前1小时,通过胃管给予或不给予MR提取物(0.4 g/kg体重),我们测量了小静脉直径、黏附白细胞数量、作为氧化应激指标的二氢罗丹明123(DHR)荧光以及肥大细胞脱颗粒情况。肠系膜I/R后观察到的肠系膜小静脉直径没有变化。MR对小静脉直径没有影响。再灌注后即刻开始出现黏附于毛细血管后小静脉壁的白细胞,并随后增加。MR治疗显著减少了黏附白细胞数量的增加。沿小静脉壁DHR荧光比率显著增加。MR减轻了氧化增加。肠系膜I/R诱导肥大细胞脱颗粒。MR抑制了肥大细胞脱颗粒的增加。总之,口服MR可减轻大鼠肠系膜中I/R诱导的微血管损伤。MR具有预防I/R相关微血管损伤的治疗潜力。